Lifecore Biomedical, Inc.
NASDAQ:LFCR
6.38 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 128.261 | 103.269 | 185.786 | 544.161 | 590.366 | 557.559 | 524.227 | 532.257 | 541.099 | 539.257 | 476.813 | 441.708 | 317.552 | 276.729 | 238.224 | 235.938 | 238.527 | 210.498 | 231.953 | 205.23 | 192.092 | 0 | 183.155 | 190.884 | 209.55 | 35.4 | 33.5 | 9.5 | 2.5 |
| Cost of Revenue
| 86.411 | 75.977 | 135.233 | 462.687 | 515.378 | 476.556 | 445.889 | 449.071 | 470.142 | 473.85 | 414.249 | 378.948 | 265.414 | 230.034 | 204.458 | 201.658 | 200.299 | 178.112 | 191.909 | 173.258 | 162.301 | 0 | 151.815 | 163.295 | 170.122 | 19.3 | 18.2 | 5.1 | 0.5 |
| Gross Profit
| 41.85 | 27.292 | 50.553 | 81.474 | 74.988 | 81.003 | 78.338 | 83.186 | 70.957 | 65.407 | 62.564 | 62.76 | 52.138 | 46.695 | 33.766 | 34.28 | 38.228 | 32.386 | 40.044 | 31.972 | 29.791 | 0 | 31.34 | 27.589 | 39.428 | 16.1 | 15.3 | 4.4 | 2 |
| Gross Profit Ratio
| 0.326 | 0.264 | 0.272 | 0.15 | 0.127 | 0.145 | 0.149 | 0.156 | 0.131 | 0.121 | 0.131 | 0.142 | 0.164 | 0.169 | 0.142 | 0.145 | 0.16 | 0.154 | 0.173 | 0.156 | 0.155 | 0 | 0.171 | 0.145 | 0.188 | 0.455 | 0.457 | 0.463 | 0.8 |
| Reseach & Development Expenses
| 8.575 | 8.24 | 7.841 | 10.222 | 11.099 | 11.466 | 12.8 | 9.473 | 7.228 | 6.988 | 7.204 | 9.294 | 9.625 | 9.275 | 4.361 | 3.665 | 3.251 | 3.074 | 3.042 | 2.543 | 3.732 | 0 | 3.664 | 3.27 | 4.696 | 5.8 | 5.7 | 7.6 | 3.8 |
| General & Administrative Expenses
| 0 | 43.013 | 42.431 | 65.264 | 72.088 | 62.762 | 50.551 | 56.308 | 47.415 | 0 | 34.723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0.005 | 0.2 | 0.1 | 0.1 | 1.3 | 1.4 | 1.9 | 2.1 | 0 | 0.447 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 40.463 | 43.018 | 42.631 | 65.364 | 72.188 | 64.062 | 51.951 | 58.208 | 49.515 | 39.958 | 35.17 | 32.531 | 26.515 | 24.608 | 17.698 | 18.017 | 19.801 | 21.616 | 27.979 | 23.412 | 22.004 | 0 | 26.418 | 26.966 | 28.879 | 11.2 | 10.8 | 4.7 | 3.3 |
| Other Expenses
| 0 | -0.729 | 3.296 | -12.799 | -4.395 | 1.6 | 2.9 | -0.333 | 1.2 | 3.107 | 10 | 8.1 | 5.331 | 4.78 | 0 | 0 | 0 | -22.669 | 0 | 0 | 0 | 0 | 0 | 0 | 6.066 | 2.2 | 2.1 | 1.1 | 0.5 |
| Operating Expenses
| 49.038 | 51.258 | 50.472 | 75.586 | 83.287 | 75.528 | 64.751 | 67.681 | 56.743 | 46.946 | 42.374 | 37.892 | 36.14 | 33.883 | 22.059 | 21.682 | 23.052 | 2.021 | 31.021 | 25.955 | 25.736 | 0 | 30.082 | 30.236 | 39.641 | 19.2 | 18.6 | 13.4 | 7.6 |
| Operating Income
| 9.331 | -26.083 | 3.458 | -6.863 | -8.299 | -8.01 | 11.848 | 15.505 | -19.786 | 18.461 | 20.19 | 24.868 | 14.577 | 8.032 | 11.707 | 12.598 | 15.176 | 30.365 | 9.023 | 6.017 | 4.055 | 0 | 1.258 | -2.647 | -0.213 | -3.1 | -3.3 | -9 | -5.6 |
| Operating Income Ratio
| 0.073 | -0.253 | 0.019 | -0.013 | -0.014 | -0.014 | 0.023 | 0.029 | -0.037 | 0.034 | 0.042 | 0.056 | 0.046 | 0.029 | 0.049 | 0.053 | 0.064 | 0.144 | 0.039 | 0.029 | 0.021 | 0 | 0.007 | -0.014 | -0.001 | -0.088 | -0.099 | -0.947 | -2.24 |
| Total Other Income Expenses Net
| 0.183 | -42.132 | -8.896 | -20.964 | -4.769 | -1.835 | 2.811 | -0.493 | 0.934 | 3.01 | 9.735 | 7.396 | 5.707 | 0.41 | 0.746 | 0.743 | 2.197 | 1.692 | -0.024 | -0.004 | 0.029 | 0 | -1.057 | -2.191 | -1.301 | 0.29 | 0.6 | 1.7 | 0.2 |
| Income Before Tax
| 9.514 | -68.702 | -51.923 | -40.466 | -51.307 | 3.64 | 16.398 | 15.012 | -18.852 | 21.471 | 29.925 | 32.264 | 20.284 | 8.442 | 8.728 | 13.341 | 16.896 | 31.645 | 8.999 | 6.013 | 4.084 | 0 | 0.201 | -4.838 | -2.126 | -2.7 | -2.7 | -7.3 | -4.1 |
| Income Before Tax Ratio
| 0.074 | -0.665 | -0.279 | -0.074 | -0.087 | 0.007 | 0.031 | 0.028 | -0.035 | 0.04 | 0.063 | 0.073 | 0.064 | 0.031 | 0.037 | 0.057 | 0.071 | 0.15 | 0.039 | 0.029 | 0.021 | 0 | 0.001 | -0.025 | -0.01 | -0.076 | -0.081 | -0.768 | -1.64 |
| Income Tax Expense
| 0.183 | 0.301 | -5.839 | -7.801 | -13.116 | 1.518 | -9.363 | 4.335 | -7.404 | 7.746 | 10.583 | 9.452 | 7.185 | 4.181 | 4.262 | 5.611 | 3.354 | 2.456 | 0.396 | 0.619 | 1.126 | 0 | 2.745 | 16.159 | -0.042 | 0.1 | 0.2 | -2.1 | -1.4 |
| Net Income
| 12.013 | -102.19 | -46.084 | -32.665 | -38.191 | 2.122 | 24.829 | 10.59 | -11.641 | 13.544 | 19.145 | 22.587 | 12.696 | 3.92 | 3.984 | 7.73 | 13.542 | 29.189 | 8.651 | 5.402 | 2.9 | 0 | -1.487 | -18.787 | -3.998 | -2.8 | -2.9 | -8.6 | -4.2 |
| Net Income Ratio
| 0.094 | -0.99 | -0.248 | -0.06 | -0.065 | 0.004 | 0.047 | 0.02 | -0.022 | 0.025 | 0.04 | 0.051 | 0.04 | 0.014 | 0.017 | 0.033 | 0.057 | 0.139 | 0.037 | 0.026 | 0.015 | 0 | -0.008 | -0.098 | -0.019 | -0.079 | -0.087 | -0.905 | -1.68 |
| EPS
| 0.39 | -3.41 | -1.56 | -1.12 | -1.31 | 0.075 | 0.9 | 0.39 | -0.43 | 0.5 | 0.71 | 0.87 | 0.5 | 0.15 | 0.15 | 0.29 | 0.52 | 1.16 | 0.35 | 0.23 | 0.11 | 0 | -0.082 | -1.15 | -0.25 | -0.28 | -0.23 | -0.77 | -0.54 |
| EPS Diluted
| 0.33 | -3.41 | -1.56 | -1.12 | -1.31 | 0.074 | 0.89 | 0.38 | -0.43 | 0.5 | 0.71 | 0.85 | 0.49 | 0.15 | 0.15 | 0.29 | 0.5 | 1.07 | 0.32 | 0.21 | 0.11 | 0 | -0.082 | -1.15 | -0.25 | -0.28 | -0.22 | -0.77 | -0.54 |
| EBITDA
| 35.604 | -35.979 | 1.964 | 13.004 | -7.161 | 23.47 | 24.987 | 26.678 | -7.798 | 30.39 | 38.689 | 41.567 | 26.994 | 14.57 | 12.242 | 17.043 | 18.38 | 33.625 | 12.226 | 9.484 | 7.76 | 0 | 4.758 | 2.783 | 4.289 | -2.29 | -1.2 | -7.9 | -3.8 |
| EBITDA Ratio
| 0.278 | -0.348 | 0.011 | 0.024 | -0.012 | 0.042 | 0.048 | 0.05 | -0.014 | 0.056 | 0.081 | 0.094 | 0.085 | 0.053 | 0.051 | 0.072 | 0.077 | 0.16 | 0.053 | 0.046 | 0.04 | 0 | 0.026 | 0.015 | 0.02 | -0.065 | -0.036 | -0.832 | -1.52 |